Yea, but then how does that look to us investors if the directors aren't even confident of there own products? If they can't get FDA approval then the whole company is functionally worthless anyway.
They can waste the $10 million in development but the extra million in setting up distribution and producton is too much?
Meanwhile, they're losing millions in lost sales, growing market share, share price
Yea, but then how does that look to us investors if the...
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.5¢ |
Change
-0.030(4.38%) |
Mkt cap ! $156.6M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 65.5¢ | $177.5K | 267.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 32772 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 12102 | 3 |
View Market Depth
| Last trade - 13.41pm 13/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |